Trasylol Removed from Market

Trasylol, a clotting drug used during cardiac surgery has been pulled from the market by Bayer after an FDA request to remove the drug due to health concerns. The FDA asked for the withdrawal after its studies found that the drug’s benefits don’t outweigh its considerable and serious adverse side effects, including death. In fact, two studies this year found the drug use increased patient mortality rates among those undergoing bypass surgery. Studies have shown that the Trasylol drug increased the risk of death, kidney damage, congestive heart failure and stroke.
Trasylol Side Effects Class Action Lawsuit